Ovarian Cancer Screening: Lessons about Effectiveness

By Pavlik Edward J.  

Diagnostics, Vol. 8, Iss. 1, 2017-12 ,pp. : 1-1

MDPI

Access to resources Recommend Favorite

Validation of the Performance of International Ovarian Tumor Analysis (IOTA) Methods in the Diagnosis of Early Stage Ovarian Cancer in a Non-Screening Population

By Froyman Wouter   Wynants Laure   Landolfo Chiara   Bourne Tom   Valentin Lil   Testa Antonia   Sladkevicius Povilas   Franchi Dorella   Fischerova Daniela   Savelli Luca   Van Calster Ben   Timmerman Dirk  

Diagnostics, Vol. 7, Iss. 2, 2017-06 ,pp. : 32-32

MDPI

Access to resources Recommend Favorite

Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials

By Ormsby Eleanor L.   Pavlik Edward J.   McGahan John P.  

Diagnostics, Vol. 7, Iss. 2, 2017-04 ,pp. : 25-25

MDPI

Access to resources Recommend Favorite

Pre-Treatment of Platinum Resistant Ovarian Cancer Cells with an MMP-9/MMP-2 Inhibitor Prior to Cisplatin Enhances Cytotoxicity as Determined by High Content Screening

By Laios Alexandros   Mohamed Bashir M.   Kelly Lynne   Flavin Richard   Finn Stephen   McEvoy Lynda   Gallagher Michael   Martin Cara   Sheils Orla   Ring Martina   Davies Anthony   Lawson Margaret   Gleeson Noreen   D’Arcy Tom   d’Adhemar Charles   Norris Lucy   Langhe Ream   Saadeh Feras Abu   O’Leary John J.   O’Toole Sharon A.  

International Journal of Molecular Sciences, Vol. 14, Iss. 1, 2013-01 ,pp. : 2085-2103

MDPI

Access to resources Recommend Favorite

HDAC6 and Ovarian Cancer

By Haakenson Joshua   Zhang Xiaohong  

International Journal of Molecular Sciences, Vol. 14, Iss. 5, 2013-05 ,pp. : 9514-9535

MDPI

Access to resources Recommend Favorite